4 - ICH-GCP-R3-Overarching-Principles-Version-March-2021.pdf
4 - Protection of Clinical Study Participants
5 - Scientific Approach in Clinical Study
6 - FDA-Guidance-1-Collecting-Comprehensive-and-Representative-Input.pdf
6 - FDA-Guidance-2-Methods-to-Identify-What-is-Important-to-Patients.pdf
6 - FDA-Guidance-3-DRAFT-Selecting-Developing-or-Modifying-Fit-for-Purpose-Clinical-Outcomes-Assessments.pdf
6 - ICH-ReflectionPaper-PFDD-FinalRevisedPostConsultation-2021-0602.pdf
6 - ICH-ReflectionPaper-PFDD-OutcomeOfPublicConsutlation-2021-0527.pdf
6 - Patient Input into Drug Development
6 - ich-reflection-paper-proposed-ich-guideline-work-advance-patient-focused-drug-development-pfdd-en.pdf